Page last updated: 2024-09-04

carbapenems and me1036

carbapenems has been researched along with me1036 in 9 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(me1036)
Trials
(me1036)
Recent Studies (post-2010) (me1036)
7,3551475,2771101

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (88.89)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirai, Y; Ida, T; Kurazono, M; Maruyama, T; Shitara, E; Yamada, K; Yonezawa, M1
Hirai, Y; Kijima, K; Kurazono, M; Nagura, J; Shitara, E; Sugano, T; Takahata, S; Takayama, Y; Tanaka, Y; Yamada, K; Yonezawa, M1
Dalziel, C; Turner, B1
Fritsche, TR; Jones, RN; Sader, HS1
Hesek, D; Lee, M; Mobashery, S; Vakulenko, SB; Villegas-Estrada, A1
Aguilar, L; Biek, D; Fenoll, A; Giménez, MJ; Granizo, JJ; Robledo, O; Tarragó, D1
Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Kurihara, S; Morinaga, Y; Nakamura, S; Ohnishi, Y; Seki, M; Yamada, Y; Yamamoto, Y; Yanagihara, K1
Biek, D; Janes, R; Morrissey, I1
Hirai, Y; Ida, T; Maebashi, K; Takahata, S; Yamada, K1

Other Studies

9 other study(ies) available for carbapenems and me1036

ArticleYear
In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8

    Topics: Bacterial Proteins; Carbapenems; Carrier Proteins; Electrophoretic Mobility Shift Assay; Gram-Negative Bacteria; Gram-Positive Bacteria; Hexosyltransferases; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Plasmids; Staphylococcus aureus

2004
Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2005
Interscience conference on antimicrobial agents and chemotherapy--46th annual meeting. Release of data for Dc-159a, and other agents. 27-30 September 2006, San Francisco, CA, USA.
    IDrugs : the investigational drugs journal, 2006, Volume: 9, Issue:11

    Topics: Animals; Anti-Infective Agents; Carbapenems; Cephalosporins; Drugs, Investigational; Estrogen Receptor Modulators; Fluoroquinolones; Humans; Naphthols; Societies, Scientific; United States

2006
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States

2008
Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics.
    Journal of the American Chemical Society, 2008, Jul-23, Volume: 130, Issue:29

    Topics: Acetylglucosamine; Anti-Bacterial Agents; Binding Sites; Biomimetic Materials; Carbapenems; Ceftaroline; Cell Wall; Cephalosporins; Circular Dichroism; Kinetics; Methicillin Resistance; Muramic Acids; Penicillin-Binding Proteins; Peptide Synthases; Peptidoglycan; Protein Conformation; Staphylococcus aureus

2008
In vitro activity of ME1036 versus other beta-lactams against penicillin-resistant Streptococcus pneumoniae serotypes exhibiting higher amoxicillin than penicillin MIC.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Carbapenems; Humans; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Spain; Streptococcus pneumoniae

2008
Efficacy of ME1036 against meticillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of haematogenous pulmonary infection.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Blood-Borne Pathogens; Carbapenems; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Pneumonia, Staphylococcal; Staphylococcus aureus; Tissue Distribution; Vancomycin; Vancomycin Resistance

2008
ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Carbapenems; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial

2009
Correlation of the antimicrobial activity of ME1036 with its binding affinities to the penicillin-binding proteins from Streptococcus pneumoniae strains.
    The Journal of antibiotics, 2011, Volume: 64, Issue:11

    Topics: Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Humans; Inhibitory Concentration 50; Microbial Viability; Models, Molecular; Molecular Structure; Penicillin-Binding Proteins; Protein Binding; Streptococcus pneumoniae

2011